Predictive Oncology Price to Free Cash Flow Ratio 2010-2024 | POAI
Historical price to free cash flow ratio values for Predictive Oncology (POAI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-03-11 | 1.07 | 0.00 | |
| 2024-09-30 | 0.79 | $-2.49 | 0.00 |
| 2024-06-30 | 1.04 | $-2.96 | 0.00 |
| 2024-03-31 | 2.55 | $-3.33 | 0.00 |
| 2023-12-31 | 3.29 | $-3.35 | 0.00 |
| 2023-09-30 | 3.20 | $-3.30 | 0.00 |
| 2023-06-30 | 4.86 | $-3.44 | 0.00 |
| 2023-03-31 | 6.54 | $-3.39 | 0.00 |
| 2022-12-31 | 6.13 | $-3.47 | 0.00 |
| 2022-09-30 | 7.20 | $-4.40 | 0.00 |
| 2022-06-30 | 8.20 | $-4.26 | 0.00 |
| 2022-03-31 | 19.54 | $-3.70 | 0.00 |
| 2021-12-31 | 19.04 | $-4.78 | 0.00 |
| 2021-09-30 | 26.60 | $-10.28 | 0.00 |
| 2021-06-30 | 26.20 | $-9.68 | 0.00 |
| 2021-03-31 | 24.20 | $-10.51 | 0.00 |
| 2020-12-31 | 14.65 | $-20.69 | 0.00 |
| 2020-09-30 | 16.28 | $-36.38 | 0.00 |
| 2020-06-30 | 32.80 | $-60.82 | 0.00 |
| 2020-03-31 | 31.51 | $-47.07 | 0.00 |
| 2019-12-31 | 52.20 | $-60.89 | 0.00 |
| 2019-09-30 | 101.00 | $-59.05 | 0.00 |
| 2019-06-30 | 149.50 | $-44.25 | 0.00 |
| 2019-03-31 | 150.00 | $-81.00 | 0.00 |
| 2018-12-31 | 123.82 | $-85.29 | 0.00 |
| 2018-09-30 | 212.00 | $-103.52 | 0.00 |
| 2018-06-30 | 226.00 | $-127.70 | 0.00 |
| 2018-03-31 | 220.00 | $-135.26 | 0.00 |
| 2017-12-31 | 202.00 | $-141.60 | 0.00 |
| 2017-09-30 | 290.72 | $-190.13 | 0.00 |
| 2017-06-30 | 294.00 | $-173.11 | 0.00 |
| 2017-03-31 | 420.00 | $94.03 | 4.47 |
| 2016-12-31 | 560.00 | $-312.73 | 0.00 |
| 2016-09-30 | 825.00 | $-243.74 | 0.00 |
| 2016-06-30 | 762.50 | $-256.59 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Enovis (ENOV) | United States | $2.475B | 16.49 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |